The Role of the Intravenous IgA and IgM-Enriched Immunoglobulin Preparation in the Treatment of Sepsis and Septic Shock

Polyclonal Intravenous Immunoglobulins (IvIg) are often administered to critically ill patients more as an act of faith than on the basis of relevant clinical studies. This particularly applies to the treatment of sepsis and septic shock because the current guidelines recommend against their use des...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical medicine 2023-07, Vol.12 (14), p.4645
Main Authors: Berlot, Giorgio, Zanchi, Silvia, Moro, Edoardo, Tomasini, Ariella, Bixio, Mattia
Format: Article
Language:English
Subjects:
Antibodies
Clinical medicine
Development and progression
Diagnosis
Drug therapy
Evidence-based medicine
Guillain-Barre syndrome
Immune system
Immunoglobulins
Immunology
Infections
Intensive care
Ligands
Lymphocytes
Myasthenia gravis
Review
Sepsis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Polyclonal Intravenous Immunoglobulins (IvIg) are often administered to critically ill patients more as an act of faith than on the basis of relevant clinical studies. This particularly applies to the treatment of sepsis and septic shock because the current guidelines recommend against their use despite many investigations that have demonstrated their beneficial effects in different subsets of patients. The biology, mechanisms of action, and clinical experience related to the administration of IvIg are reviewed, which aim to give a more in-depth understanding of their properties in order to clarify their possible indications in sepsis and septic shock patients.
ISSN:2077-0383
2077-0383
DOI:10.3390/jcm12144645